Timber Pharmaceuticals, Inc. TMBR
0.34 +0.34
Day range unavailable
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) —
Ratings (-1m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 1
- 2 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.26 | -1.26 – -1.26 | -2.50 | +49.6% | 0 | 0.0% | 1 |
| Next quarter | -1.30 | -1.30 – -1.30 | -7.50 | +82.7% | 0 | 0.0% | 1 |
| Current year | -5.20 | -5.20 – -5.20 | -9.19 | +43.4% | 0 | 0.0% | 1 |
| Next year | -5.51 | -5.51 – -5.51 | -5.20 | -6.0% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 27, 2023 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Apr 9, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |